XALKORI® (crizotinib) For ALK+ or ROS1+ mNSCLC ... | 合法藥品大搜索

XALKORI®(crizotinib)isaprescriptionmedicineusedtotreatpeoplewithnon-smallcelllungcancer(NSCLC)thathasspreadtootherpartsofthebodyandis ...

is here for you:

Financial assistance

We’ll help you find financial assistance options for your prescribed XALKORI, including a co-pay savings program for eligible, commercially insured patients. Limits, terms, and conditions apply.* We can also help identify resources if you have Medicare, another government insurance plan, or don’t have health insurance.

*Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico. Patients may receive up to $25,000 per product in savings annually. The offer wi...

【篤實關懷倫理卓越】光田綜合醫院Kuang Tien General Hospital | 合法藥品大搜索

商品名, XALKORI ☆ 250MG(需事審), 藥品許可證, 衛署藥輸字第025938號. 中文名, 截剋瘤膠囊, 健保局藥理類別, 100000 抗癌藥物. 學名, Crizotinib, 外觀描述 ... Read More

截剋瘤®膠囊200毫克，250毫克Xalkori® Capsules 200 mg ... | 合法藥品大搜索

2015年12月15日 — 應由有使用抗癌藥物之經驗的醫師開始施行XALKORI 的治療並進行監督。 ALK 檢驗. 1. Page 2. Version: 201405-2. Read More

國軍高雄總醫院 | 合法藥品大搜索

2021年3月12日 — XALKORI 250mg/cap. 商品中文名. 截剋瘤膠囊250毫克. 學名. Crizotinib. 廠牌. PFIZER MANUFACTURING DEUTSCHLAND GMBH. 院內碼. Read More

0804 | 合法藥品大搜索

XALKORI 適用於治療ROS-1陽性的晚期非小細胞肺癌(NSCLC)病人。 4.2 用法用上. 應由有使用抗癌藥物之經驗的醫師開始施行XALKORI的治療並進. 行 ... Read More

健保署公告：修訂含crizotinib成分藥品（如Xalkori ... | 合法藥品大搜索

修訂後給付規定. 原給付規定. 9.50. Crizotinib (如Xalkori)：(104/9/1、106/11/1、107/5/1、108/7/1、108/9/1)： 1.適用於ALK陽性之晚期非小細胞肺癌患者。 Read More

非小細胞肺癌用藥Crizotinib (Xalkori ® ) 健保價申覆口頭報告 | 合法藥品大搜索

Crizotinib (Xalkori ® ). 健保價申覆口頭報告. 臺大醫院施金元醫師. Jun 18, 2015. 2. DRAFT – Subject to Further Review – Company Confidential and Proprietary ... Read More

截剋瘤膠囊250 毫克200 毫克(Xalkori® Capsules 250mg ... | 合法藥品大搜索

方法來篩選出適合使用Xalkori 治療的患者。ALK 陽性NSCLC. 的評估應由可熟練操作特殊檢驗技術的實驗室來進行。建議健保給付之適應. 症內容. 曾接受一種含鉑 ... Read More

XALKORI® (crizotinib) For ALK+ or ROS1+ mNSCLC ... | 合法藥品大搜索

XALKORI® (crizotinib) is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is ... Read More